An overview of environmental risk factors in systemic sclerosis

References

• Barnes J, Mayes MD. Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers. Curr Opin Rheumatol. 2012;24:165–170.
   PubMed Web of Science ®Google Scholar
• De Martinis M, Ginaldi L. Capillaroscopy opens a window to look inside. Rheumatology (Sunnyvale). 2014;4:e112. DOI:10.4172/2161-1149.10004e112.
   Google Scholar
• LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15:202–205.
   PubMed Web of Science ®Google Scholar
• Moinzadeh P, Aberer E, Ahmadi-Simab K, et al., all participating DNSS centers. Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis. 2015;74(4):730–737.
   PubMed Web of Science ®Google Scholar
• Masi AT, Rodnan GP, Medsger TA, et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23:581–590.
   PubMed Web of Science ®Google Scholar
• Feghali-Bostwick C, Medsger TA Jr, Wright TM. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum. 2003;48:1956–1963.
   PubMed Web of Science ®Google Scholar
• Bogdanos DP, Smyk DS, Rigopoulou EI, et al. Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun. 2010;9:A311–A318.
   Web of Science ®Google Scholar
• Alonso-Ruiz A, Zea-Mendoza AC, Salazar-Vailinas JM, et al. Toxic oil syndrome: a syndrome with features overlapping those of various forms of scleroderma. Semin Arthritis Rheum. 1986;15:200–212.
   PubMed Web of Science ®Google Scholar
• Harris DK, Adams WGF. Acroosteolysis occurring in men engaged in the polymerisation of vinyl-chloride. Br Med J. 1967;3:712–714.
   PubMed Web of Science ®Google Scholar
• Shapira Y, Agmon-Levin N, Shoenfeld Y. Geoepidemiology of autoimmune rheumatic diseases. Nat Rev Rheumatol. 2010;6:468–476.
   PubMed Web of Science ®Google Scholar
• Arnson Y, Amital H, Agmon-Levin N, et al. Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature. Autoimmun Rev. 2011;10:490–494.
   PubMed Web of Science ®Google Scholar
• De Martinis M, Ginaldi L. Rethinking the ‘sunshine’ vitamin. J Osteopor Phys Act. 2014;2:e110. DOI:10.4172/2329-9509.1000e110.
   Google Scholar
• Ranque B, Mouthon L. Geoepidemiology of systemic sclerosis. Autoimmun Rev. 2010;9:A311–A318.
   PubMed Web of Science ®Google Scholar
• de Shazo RD. Current concepts about the pathogenesis of silicosis and asbestosis. J Allergy Clin Immunol. 1982;70:41–49.
   PubMed Web of Science ®Google Scholar
• Haustein U, Ziegler V, Herrman K. Environmental scleroderma. Clin Dermatol. 1994;12:467–473.
   PubMed Web of Science ®Google Scholar
• Goldman J. Connective tissue disease in people exposed to organic chemical solvents: systemic sclerosis (scleroderma) in dry cleaning plant and aircraft industry workers. J Clin Rheumatol. 1996;2:185–190.
   PubMedGoogle Scholar
• Bottomley WW, Sheehan-Dare RA, Hughes P, et al. A sclerodermatous syndrome with unusual features following prolonged occupational exposure to organic solvents. Br J Dermatol. 1993;128:203–206.
   PubMed Web of Science ®Google Scholar
• Gourley M. Miller FW Mechanisms of disease: environmental factors in the pathogenesis of rheumatic disease. Nat Clin Pract Rheumatol. 2007;3:172–180.
   PubMedGoogle Scholar
• Wang Y, Fan PS, Kahaleh B. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. Arthritis Rheum. 2006;5:2271–2279.
   Web of Science ®Google Scholar
• Koeger AC, Lang T, Alcaix D, et al. Silica-associated connective tissue disease. A study of 24 cases. Medicine (Baltimore). 1995;74:221–237.
   PubMed Web of Science ®Google Scholar
• Byers VS, Levin AS, Ozonoff DM, et al. Association between clinical symptoms and lymphocyte abnormalities in a population with chronic domestic exposure to industrial solvent-contaminated domestic water supply and a high incidence of leukaemia. Cancer Immunol Immunother. 1988;27:77–81.
   PubMed Web of Science ®Google Scholar
• Lunardi C, Dolcino M, Peterlana D, et al. Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach. PLoS Med. 2006;3:94–108.
   Web of Science ®Google Scholar
• Erasmus LD. Scleroderma in goldminers on the Witwatersrand with particular reference to pulmonary manifestations. S Afr Lab Clin Med. 1957;3:209–231.
   PubMedGoogle Scholar
• Sluis-Cremer GK, Hassel PA, Nizdo EH, et al. Silica, silicosis and progressive systemic sclerosis. Br J Ind Med. 1985;41:838–843.
   Google Scholar
• Bovenzi M, Barbone F, Betta A, et al. Scleroderma and occupational exposure. Scand J Work Environ Health. 1995;21:289–292.
   PubMed Web of Science ®Google Scholar
• Englert H, Small-McMahon J, Davis K, et al. Male systemic sclerosis and occupational silica exposure—a population-based study. Aust NZ J Med. 2000;30:215–220.
   PubMedGoogle Scholar
• Diot E, Lesire V, Guilmot JL, et al. Systemic sclerosis and occupational risk factors: a case–control study. Occup Environ Med. 2002;59:545–549.
   PubMed Web of Science ®Google Scholar
• Burns CJ, Laing TJ, Gillespie BW, et al. The epidemiology of scleroderma among women: assessment of risk from exposure to silicone and silica. J Rheumatol. 1996;23:1904–1911.
   PubMed Web of Science ®Google Scholar
• Walsh SJ. Effects of non-mining occupational silica exposure on proportional mortality from silicosis and systemic sclerosis. J Rheumatol. 1999;26:2179–2185.
   PubMed Web of Science ®Google Scholar
• McCormic ZD, Khuder SS, Aryal BK, et al. Occupational silica exposure as a risk factor for scleroderma: a meta-analysis. Int Arch Occup Environ Health. 2010;83:763–769.
   PubMed Web of Science ®Google Scholar
• Marie I, Gehanno JF, Bubenheim M, et al. Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature. Autoimmun Rev. 2014;13:151–156.
   PubMed Web of Science ®Google Scholar
• Reinl W. Sklerodermie durch trichloräthylen-einwirkung?. Zent Arb Arb. 1957;7:58–60.
   Google Scholar
• Nietert PJ, Sutherland SE, Silver RM, et al. Is occupational organic solvent exposure a risk factor for scleroderma?. Arthritis Rheum. 1998;41:1111–1118.
   PubMed Web of Science ®Google Scholar
• Garabrant DH, Lacey JV, Laing TJ, et al. Scleroderma and solvent exposure among women. Am J Epidemiol. 2003;157:493–500.
   PubMed Web of Science ®Google Scholar
• Bovenzi M, Barbone F, Pisa FE, et al. A case–control study of occupational exposures and systemic sclerosis. Int Arch Occup Environ Health. 2004;77:10–16.
   PubMed Web of Science ®Google Scholar
• Kütting B, Uter W, Drexler H. Is occupational exposure to solvents associated with an increased risk for developing systemic scleroderma?. J Occup Med Toxicol. 2006;3(1):15.
   Google Scholar
• Silman AJ, Jones S. What is the contribution of occupational environmental factors to the occurrence of scleroderma in men?. Ann Rheum Dis. 1992;51:1322–1324.
   PubMed Web of Science ®Google Scholar
• Aryal BK, Khuder SA, Schaub EA. Meta-analysis of systemic sclerosis and exposure to solvents. Am J Ind Med. 2001;40:271–274.
   PubMed Web of Science ®Google Scholar
• Barragán-Martínez C, Speck-Hernández CA, Montoya-Ortiz G, et al. Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis. PLoS One. 2012;7:e51506.
   PubMed Web of Science ®Google Scholar
• Ishikawa O, Warita S, Tamura A, et al. Occupational scleroderma. A 17-year follow-up study. Br J Dermatol. 1995;133:786–789.
   PubMed Web of Science ®Google Scholar
• Fessel WJ. Scleroderma and welding. N EngI J Med. 1977;296:1537.
   PubMed Web of Science ®Google Scholar
• Dunnill MGS, Black MM. Scierodermatous syndrome after occupational exposure to herbicides-response to systemic steroids. Clin Exp Dermatol. 1994;19:518–520.
   PubMed Web of Science ®Google Scholar
• Lambert M, Hatron PY, Hachulla E, et al. Hypothenar hammer syndrome followed by systemic sclerosis. J Rheumatol. 2000;27:2516–2517.
   PubMed Web of Science ®Google Scholar
• Bovenzi M, Barbone F, Pisa FE, et al. Scleroderma and occupational exposure to hand-transmitted vibration. Int Arch Occup Environ Health. 2001;74:579–582.
   PubMed Web of Science ®Google Scholar
• Yamakage A, Ishikawa H. Generalized morphea-like scleroderma occurring in people exposed to organic solvents. Dermatologica. 1982;165:186–193.
   PubMedGoogle Scholar
• Czirják L, Schlammadinger J, Szegedi G. Systemic sclerosis and exposure to trichloroethylene. Dermatology. 1993;186:236.
   PubMed Web of Science ®Google Scholar
• Brasington RD Jr, Thorpe-Swenson AJ. Systemic sclerosis associated with cutaneous exposure to solvent: case report and review of the literature. Arthritis Rheum. 1991;34:631–633.
   PubMed Web of Science ®Google Scholar
• Czirjak L, Danko K, Schlammadinger J, et al. Progressive systemic sclerosis occurring in patients exposed to chemicals. Int J Dermatol. 1987;26:374–378.
   PubMed Web of Science ®Google Scholar
• Kettaneh A, Al MO, Tiev KP, et al. Occupational exposure to solvents and gender-related risk of systemic sclerosis: a metaanalysis of case-control studies. J Rheumatol. 2007;34:97–103.
   PubMed Web of Science ®Google Scholar
• De Roos AJ, Cooper GS, Alavanja MC, et al. Rheumatoid arthritis among women in the agricultural health study: risk associated with farming activities and exposures. Ann Epidemiol. 2005;15:762–770.
   PubMed Web of Science ®Google Scholar
• Cooper GS, Parks CG, Treadwell EL, et al. Occupational risk factors for the development of systemic lupus erythematosus. J Rheumatol. 2004;31:1928–1933.
   PubMed Web of Science ®Google Scholar
• Noel B, Holtz J, Savolainen H, et al. Hand-arm vibration syndrome with proximal ulnar artery occlusion. Vasa. 1998;27:176–178.
   PubMed Web of Science ®Google Scholar
• Mayes MD. Epidemiologic studies of environmental agents and systemic autoimmune diseases. Environ Health Perspect. 1999;107:743–748.
   PubMed Web of Science ®Google Scholar
• Noel B. Pathophysiology and classification of the vibration white finger. Int Arch Occup Environ Health. 2000;73:150–155.
   PubMed Web of Science ®Google Scholar
• Kahaleh MB, LeRoy EC. Autoimmunity and vascular involvement in systemic sclerosis. Autoimmunity. 1999;31:195–214.
   PubMed Web of Science ®Google Scholar
• Smyk DS, Koutsoumpas AL, Mytilinaiou MG, et al. Helicobacter pylori and autoimmune disease: cause or bystander. World J Gastroenterol. 2014;20:613–629.
   PubMed Web of Science ®Google Scholar
• Gasbarrini A, Massari I, Serricchio M, et al. Helicobacter pylori eradication ameliorates primary Raynaud’s phenomenon. Dig Dis Sci. 1998;43:1641–1645.
   PubMed Web of Science ®Google Scholar
• Csiki Z, Gal I, Sebesi J, et al. Raynaud syndrome and eradication of Helicobacter pylori. Orv Hetil. 2000;141:2827–2829.
   PubMedGoogle Scholar
• Yazawa N, Fujimoto M, Kikuchi K, et al. High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: association with esophageal involvement. J Rheumatol. 1998;25:650–653.
   PubMed Web of Science ®Google Scholar
• Farina G, Rosato E, Francia C, et al. High incidence of Helicobacter pylori infection in patients with systemic sclerosis: association with Sicca Syndrome. Int J Immunopathol Pharmacol. 2001;14:81–85.
   PubMed Web of Science ®Google Scholar
• Ram M, Barzilai O, Shapira Y, et al. Helicobacter pylori serology in autoimmune diseases – fact or fiction? Clin Chem Lab Med. 2013;51:1075–1082.
   PubMed Web of Science ®Google Scholar
• Savarino V, Sulli A, Zentilin P, et al. No evidence of an association between Helicobacter pylori infection and Raynaud phenomenon. Scand J Gastroenterol. 2000;35:1251–1254.
   PubMed Web of Science ®Google Scholar
• Sulli A, Seriolo B, Savarino V, et al. Lack of correlation between gastric Helicobacter pylori infection and primary or secondary Raynaud’s phenomenon in patients with systemic sclerosis. J Rheumatol. 2000;27:1820–1821.
   PubMed Web of Science ®Google Scholar
• Moroncini G, Mori S, Tonnini C, et al. Role of viral infections in the etiopathogenesis of systemic sclerosis. Clin Exp Rheumatol. 2013;31:3–7.
   PubMedGoogle Scholar
• Neidhart M, Kuchen S, Distler O, et al. Increased serum levels of antibodies against human cytomegalovirus and prevalence of autoantibodies in systemic sclerosis. Arthritis Rheum. 1999;42(2):389–392.
   PubMed Web of Science ®Google Scholar
• Ohtsuka T, Yamazaki S. Increased prevalence of human parvovirus B19 in systemic sclerosis skin. Brit J Dermatol. 2004;150:1091–1109.
   PubMed Web of Science ®Google Scholar
• Artuković M, Ikić M, Kustelega J, et al. Influence of UV radiation on immunological system and occurrence of autoimmune diseases. Coll Antropol. 2010;34:175–178.
   PubMedGoogle Scholar
• Chaudhary P, Chen X, Assassi S, et al. Cigarette smoking is not a risk factor for systemic sclerosis. Arthritis Rheum. 2011;63:3098–3102.
   PubMed Web of Science ®Google Scholar
• Beebe JL, Lacey JV Jr, Mayes MD, et al. Reproductive history, oral contraceptive use, estrogen replacement therapy and the risk of developing scleroderma. Arthritis Rheum. 1997;40:S100.
   Google Scholar
• Finch WR, Rodnan GP, Buckingham RB, et al. Bleomycin-induced scleroderma. J Rheumatol. 1980;7(5):651–659.
   PubMed Web of Science ®Google Scholar
• Kerr LD, Spiera H. Scleroderma in association with the use of bleomycin: a report of 3 cases. J Rheumatol. 1992;19(2):294–296.
   PubMed Web of Science ®Google Scholar
• Levy Y, Rotman-Pikielny P, Ehrenfeld M, et al. Silicone breast implantation-induced scleroderma: description of four patients and a critical review of the literature. Lupus. 2009;18:1226–1232.
   PubMed Web of Science ®Google Scholar
• Al Aranji G, White D, Solanki K. Scleroderma renal crisis following silicone breast implant rupture: a case report and review of the literature. Clin Exp Rheumatol. 2014;32:262–266.
   PubMed Web of Science ®Google Scholar
• Hochberg MC, Perlmutter DL, Medsger TA Jr, et al. Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma). Arthritis Rheum. 1996;39:1125–1131.
   PubMed Web of Science ®Google Scholar
• Lee IM, Cook NR, Shadick NA, et al. Prospective cohort study of breast implants and the risk of connective-tissue diseases. Int J Epidemiol. 2011;40:230–238.
   PubMed Web of Science ®Google Scholar
• Dangler CA, Baker SE, Njenga MK, et al. Murine cytomegalovirus-associated arteritis. Vet Pathol. 1995;32:127–133.
   PubMed Web of Science ®Google Scholar
• Vaughan JH, Shaw PX, Nguyen MD, et al. Evidence of activation of 2 herpesviruses, Epstein-Barr virus and cytomegalovirus, in systemic sclerosis and normal skins. J Rheumatol. 2000;27(3):821–823.
   PubMed Web of Science ®Google Scholar
• Lunardi C, Bason C, Navone R, et al. Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med. 2000;6(10):1183–1186.
   PubMed Web of Science ®Google Scholar
• Magro CM, Nuovo G, Ferri C, et al. Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma. J Cutan Pathol. 2004;31(1):43–50.
   PubMed Web of Science ®Google Scholar
• Ferri C, Azzi A, Magro CM. Parvovirus B19 and systemic sclerosis. Br J Dermatol. 2005;152(4):819–820.
   PubMed Web of Science ®Google Scholar
• Meyer O. Parvovirus B19 and autoimmune diseases. Joint Bone Spine. 2003;70(1):6–11.
   PubMed Web of Science ®Google Scholar
• Kroft EB, Berkhof NJ, van de Kerkhof PC, et al. Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review. J Am Acad Dermatol. 2008;59:1017–1030.
   PubMed Web of Science ®Google Scholar
• Harel-Meir M, Sherer Y, Shoenfeld Y. Tobacco smoking and autoimmune rheumatic diseases. Nat Clin Pract Rheumatol. 2007;3:707–715.
   PubMedGoogle Scholar
• Harrison BJ, Silman AJ, Hider SL, et al. Cigarette smoking as a significant risk factor for digital vascular disease in patients with systemic sclerosis. Arthritis Rheum. 2002;46:3312–3316.
   PubMed Web of Science ®Google Scholar
• Hudson M, Lo E, Lu Y, et al. Cigarette smoking in patients with systemic sclerosis. Arthritis Rheum. 2011;63:230–238.
   PubMed Web of Science ®Google Scholar
• Maheux R, Naud F, Rioux M, et al. A randomized, double-blind, placebo-controlled study on the effect of conjugated estrogens on skin thickness. Am J Obstet Gynecol. 1994;15:642–649.
   Google Scholar
• Hall G, Phillips TJ. Estrogen and skin: the effects of estrogen, menopause, and hormone replacement therapy on the skin. J Am Acad Dermatol. 2005;15:555–568.
   Web of Science ®Google Scholar
• Aida-Yasuoka K, Peoples C, Yasuoka H, et al. Estradiol promotes the development of a fibrotic phenotype and is increased in the serum of patients with systemic sclerosis. Arthritis Res Ther. 2013;10:15–R10.
   Google Scholar
• Fraenkel L, Zhang Y, Chaisson CE, et al. The association of estrogen replacement therapy and the Raynaud phenomenon in postmenopausal women. Ann Intern Med. 1998;129:208–211.
   PubMed Web of Science ®Google Scholar
• Remlinger KA. Cutaneous reactions to chemotherapy drugs. The art of consultation. Arch Dermatol. 2003;139(1):77–81.
   PubMedGoogle Scholar
• Yamamoto T, Takagawa S, Katayama I, et al. Animal model of sclerotic skin. I: local injections of bleomycin induce sclerotic skin mimicking scleroderma. J Invest Dermatol. 1999;112(4):456–462.
   PubMed Web of Science ®Google Scholar
• Miller FW, Alfredsson L, Costenbader KH, et al. Epidemiology of environmental exposures and human autoimmune diseases: findings from a national institute of environmental health sciences expert panel workshop. J Autoimmun. 2012;39:259–271.
   PubMed Web of Science ®Google Scholar
• Dospinescu P, Jones GT, Basu N. Environmental risk factors in systemic sclerosis. Curr Opin Rheumatol. 2013;25:179–183.
   PubMed Web of Science ®Google Scholar